| # | Title | Journal | Year | Citations |
|---|
| 1 | Sexually transmitted diseases treatment guidelines, 2010 | MMWR Recommendations and Reports | 2010 | 4,415 |
| 2 | Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel | MMWR Recommendations and Reports | 2006 | 3,977 |
| 3 | Progressing toward tuberculosis elimination in low-incidence areas of the United States. Recommendations of the Advisory Council for the Elimination of Tuberculosis | MMWR Recommendations and Reports | 2002 | 2,733 |
| 4 | Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005 | MMWR Recommendations and Reports | 2005 | 2,529 |
| 5 | CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 | MMWR Recommendations and Reports | 2016 | 2,317 |
| 6 | Guidelines for infection control in dental health-care settings--2003 | MMWR Recommendations and Reports | 2003 | 2,257 |
| 7 | Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories | MMWR Recommendations and Reports | 2009 | 2,047 |
| 8 | Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008 | MMWR Recommendations and Reports | 2008 | 1,985 |
| 9 | Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group | MMWR Recommendations and Reports | 2001 | 1,730 |
| 10 | Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America | MMWR Recommendations and Reports | 2004 | 1,578 |
| 11 | CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management | MMWR Recommendations and Reports | 2013 | 1,468 |
| 12 | Clinical guidance for smallpox vaccine use in a postevent vaccination program | MMWR Recommendations and Reports | 2015 | 1,399 |
| 13 | Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 2011 | 1,394 |
| 14 | Effects on violence of laws and policies facilitating the transfer of youth from the juvenile to the adult justice system: a report on recommendations of the Task Force on Community Preventive Services | MMWR Recommendations and Reports | 2007 | 1,380 |
| 15 | Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | MMWR Recommendations and Reports | 2006 | 1,290 |
| 16 | Strategies for reducing exposure to environmental tobacco smoke, increasing tobacco-use cessation, and reducing initiation in communities and health-care systems. A report on recommendations of the Task Force on Community Preventive Services | MMWR Recommendations and Reports | 2000 | 1,223 |
| 17 | Sexually transmitted diseases treatment guidelines, 2015 | MMWR Recommendations and Reports | 2015 | 1,132 |
| 18 | Updated preparedness and response framework for influenza pandemics | MMWR Recommendations and Reports | 2014 | 1,113 |
| 19 | Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention | MMWR Recommendations and Reports | 1998 | 1,077 |
| 20 | Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use--supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP) | MMWR Recommendations and Reports | 1992 | 1,047 |
| 21 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season | MMWR Recommendations and Reports | 2018 | 963 |
| 22 | Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services | MMWR Recommendations and Reports | 2012 | 949 |
| 23 | 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | MMWR Recommendations and Reports | 1992 | 921 |
| 24 | Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC) | MMWR Recommendations and Reports | 1997 | 912 |
| 25 | Sexually Transmitted Infections Treatment Guidelines, 2021 | MMWR Recommendations and Reports | 2021 | 841 |
| 26 | Core Elements of Outpatient Antibiotic Stewardship | MMWR Recommendations and Reports | 2016 | 776 |
| 27 | Neuraminidase inhibitors for treatment of influenza A and B infections | MMWR Recommendations and Reports | 1999 | 637 |
| 28 | Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 2007 | 614 |
| 29 | U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 | MMWR Recommendations and Reports | 2016 | 609 |
| 30 | Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 1996 | 597 |
| 31 | Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | MMWR Recommendations and Reports | 2010 | 589 |
| 32 | Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010 | MMWR Recommendations and Reports | 2010 | 588 |
| 33 | Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America | MMWR Recommendations and Reports | 2009 | 542 |
| 34 | Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices | MMWR Recommendations and Reports | 2018 | 500 |
| 35 | Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States | MMWR Recommendations and Reports | 2005 | 471 |
| 36 | Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 | MMWR Recommendations and Reports | 2012 | 463 |
| 37 | Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | MMWR Recommendations and Reports | 1998 | 446 |
| 38 | Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident | MMWR Recommendations and Reports | 2015 | 438 |
| 39 | Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010 | MMWR Recommendations and Reports | 2010 | 422 |
| 40 | Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention | MMWR Recommendations and Reports | 1994 | 393 |
| 41 | Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 2014 | 387 |
| 42 | CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022 | MMWR Recommendations and Reports | 2022 | 385 |
| 43 | Sexually transmitted diseases treatment guidelines, 2006 | MMWR Recommendations and Reports | 2006 | 361 |
| 44 | Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis — United States | MMWR Recommendations and Reports | 2016 | 357 |
| 45 | Prevention and Control of Seasonal Influenza with Vaccines | MMWR Recommendations and Reports | 2016 | 357 |
| 46 | Recommended infection-control practices for dentistry, 1993. Centers for Disease Control and Prevention | MMWR Recommendations and Reports | 1993 | 355 |
| 47 | Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 2008 | 354 |
| 48 | Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care | MMWR Recommendations and Reports | 2006 | 353 |
| 49 | Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017 | MMWR Recommendations and Reports | 2017 | 349 |
| 50 | Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP) | MMWR Recommendations and Reports | 2011 | 340 |
